Search results for "Soft Tissue Neoplasm"

showing 10 items of 52 documents

Pigmented villonodular synovitis of the shoulder: review and case report

1999

Pigmented villonodular synovitis (PVNS) as reviewed in detail elsewhere most frequently involves the knee and finger synovial structures; shoulder involvement is rare: A search through the English literature yielded 18 publications describing 25 cases of PVNS affecting the shoulder joint. Analyzing these reports we found the clinical and radiological findings generally to be nonspecific, often mimicking a malignancy, as in the case presented here of a 16-year-old boy with painful swelling in the area of the left proximal humerus. Magnetic resonance imaging showed a suspected malignant soft tissue mass involving the shoulder capsule and measuring 7.5 x 6 x 4 cm. Preoperatively the patient co…

Malemusculoskeletal diseasesmedicine.medical_specialtyAdolescentSoft Tissue NeoplasmsSynovitis Pigmented VillonodularMalignancyDiagnosis DifferentialSynovitismedicineHumansOrthopedics and Sports MedicineShoulder Jointbusiness.industrymedicine.diseaseMagnetic Resonance ImagingTendonSurgerymedicine.anatomical_structurePigmented villonodular synovitisOrthopedic surgerySurgeryShoulder jointRadiologyPresentation (obstetrics)Differential diagnosisbusinessKnee Surgery, Sports Traumatology, Arthroscopy
researchProduct

An experimental comparison of the K- and L-Auger electron spectra generated in the decays of 140Nd and 111In

2005

The low-energy electron spectra generated in the decay of 140Nd have been measured using a combined electrostatic spectrometer adjusted to the 4, 7, and 35 eV instrumental resolution. In order to estimate the therapeutic potential of low-energy electrons associated with the decay of 140Nd, similar experiments have been performed with 111In. Relative Auger electron intensity ratios per decay are: 111In(K-Auger)/140Nd(K-Auger)=1.47(12), 111In(L-Auger) /140Nd(L-Auger)=1.1(4), and 111In(L-Auger [2.8-7 keV])/140Nd(L-Auger [2.8-7 keV])=0.24(11). The obtained K-Auger group intensity ratios have been compared with results of calculations. The good agreement found for the experimental and estimated …

NeodymiumRadioisotopesAuger electron spectroscopyRadiationSpectrometerRelative intensityChemistryElectron spectraSpectrum AnalysisResolution (electron density)Soft Tissue NeoplasmsDNA NeoplasmElectronSpectral lineAtomic physicsAtomic dataApplied Radiation and Isotopes
researchProduct

Clinical, pathologic, and genetic features of massive soft tissue neurofibromas in a Sicilian patient

2008

Abstract CONTEXT: Lipase maturation factor 1 (LMF1) gene is a novel candidate gene in severe hypertriglyceridemia. Lmf1 is involved in the maturation of lipoprotein lipase (LPL) and hepatic lipase in endoplasmic reticulum. To date only one patient with severe hypertriglyceridemia and related disorders was found to be homozygous for a nonsense mutation in LMF1 gene (Y439X). OBJECTIVE: The objective of the study was to investigate LMF1 gene in hypertriglyceridemic patients in whom mutations in LPL, APOC2, and APOA5 genes had been excluded. RESULTS: The resequencing of LMF1 gene led to the discovery of a novel homozygous nonsense mutation in one patient with severe hypertriglyceridemia and rec…

Nonsynonymous substitutionMalecongenital hereditary and neonatal diseases and abnormalitiesPathologymedicine.medical_specialtyHeterozygoteNeurofibromatosis 1BiopsyDNA Mutational AnalysisMutation MissenseSoft Tissue NeoplasmsDermatologymassive soft tissue neurofibromas NeurofibromatosisBiologymedicine.disease_causeFrameshift mutationExonGenes Neurofibromatosis 1medicineSettore MED/35 - Malattie Cutanee E VenereeMissense mutationHumansNeurofibromatosisFrameshift MutationGeneSicilyGeneticsMutationHeterozygote advantageGeneral MedicineExonsMiddle Agedmedicine.diseasenervous system diseasesGene Expression Regulation NeoplasticButtocks
researchProduct

Safety and activity of trastuzumab-containing therapies for the treatment of metastatic breast cancer: our long-term clinical experience (GOIM study).

2007

Background: Trastuzumab is widely used as the treatment of choice for HER2-positive metastatic breast cancer (MBC). Patients and methods: Seventy patients, median age 57 years and range 31-81 years, were included in our retrospective analysis with the aim to evaluate safety and activity of trastuzumab-containing therapies. Results: We observed for first-line treatment response rate (RR) 41%, stable disease (SD) 47% and time to progression (TTP) 8 months (range 1-44). Corresponding numbers for second line were RR 23%, SD 62% and (TTP) 9 months (range 3-23) and beyond second line RR 22%, SD 78% and (TTP) 9 months (range 4-19). Overall survival was 19.2 months (3-62 months). The median cumulat…

OncologyAdultmedicine.medical_specialtyDrug-Related Side Effects and Adverse Reactionscardiac safety clinical experience heavily pretreated women metastatic breast cancer retrospective analysis trastuzumabAntineoplastic AgentsBone NeoplasmsBreast NeoplasmsSoft Tissue NeoplasmsAntibodies Monoclonal HumanizedAsymptomaticMetastasisBreast cancerTrastuzumabcardiac safety; clinical experience; heavily pretreated women; metastatic breast cancer; retrospective analysis; trastuzumabInternal medicineAntineoplastic Combined Chemotherapy ProtocolsmedicineHumansskin and connective tissue diseasesAdverse effectneoplasmsAgedRetrospective StudiesAged 80 and overEjection fractionbusiness.industryCumulative doseAntibodies MonoclonalHematologyMiddle AgedTrastuzumabmedicine.diseaseMetastatic breast cancerSurgeryTreatment OutcomeOncologyFemalemedicine.symptombusinessmedicine.drugAnnals of oncology : official journal of the European Society for Medical Oncology
researchProduct

Oral Rhabdomyosarcoma: a review

2012

Rhabdomyosarcoma (RMS) is a rare malignant soft tissue neoplasm comprised of cells derived from the primitive mesen¬chyme. About 35% of RMS arises in the head and neck, are are classified as parameningeal and non-parameningeal forms. These are the most common soft tissue sarcoma of the children, adolescents and young adults. Their etiopathogenesis and its molecular relevance have been emphasized. The first line of treatment is radical excision and this is usually supplemented by radiotherapy. It is believed that adjunct combination chemotherapy may greatly improve the prognosis. Inadequately treated tumours grow in an infiltrative manner and recur in a high percentage of cases. Bone does no…

Pathologymedicine.medical_specialtyOral Medicine and Pathologybusiness.industryFirst linemedicine.medical_treatmentSoft tissue sarcomaCombination chemotherapyMalignant Soft Tissue NeoplasmParameningealOdontologíaReviewmedicine.disease:CIENCIAS MÉDICAS [UNESCO]Ciencias de la saludRadiation therapyUNESCO::CIENCIAS MÉDICASMedicinebusinessHead and neckRhabdomyosarcomaGeneral Dentistry
researchProduct

Nonepithelial skin tumors with multinucleated giant cells

2013

Recognition of the different types of multinucleated giant cells in neoplastic and pseudotumoral lesions of the skin may be helpful in the differential diagnosis of these tumors. In this review, we will analyze the different types of multinucleated giant cells that can be found in nonepithelial cutaneous tumors and, more importantly, the clinicopathological context in which they are found. Touton giant cells are typically present in juvenile xanthogranuloma, necrobiotic xanthogranuloma, and some subtypes of xanthomas. Giant cells with a ground glass appearance are typically present in the solitary reticulohistiocytoma and multicentric reticulohistiocytosis. Osteoclast-like cells are found i…

Pathologymedicine.medical_specialtySkin NeoplasmsHistiocytosis Non-Langerhans-CellJuvenile xanthogranulomaSoft Tissue NeoplasmsFibromaBiologyGiant CellsPathology and Forensic MedicineTouton giant cellXanthomatosismedicineHumansGiant Cell TumorsNecrobiotic xanthogranulomaHistiocytoma Benign FibrousPlexiform fibrohistiocytic tumorDermatofibrosarcomaGiant Cell TumorsAtypical fibroxanthomamedicine.diseaseGiant cellLipomaPleomorphic lipomaXanthogranuloma JuvenileSeminars in Diagnostic Pathology
researchProduct

A review of oral biopsies in children and adolescents: a clinicopathological study of a case series

2013

Objective: The aim of this study was to evaluate the clinicopathological features of oral lesions in children and adolescents diagnosed in an Oral Pathology Laboratory. Study design: Between 2000 and 2010, all oral lesions diagnosed in patients younger than 18 years old, from the Oral Pathology Laboratory, Federal University of Pernambuco, Brazil, were selected for the study. The clinical data were obtained from the patient charts filed in the Laboratory. All cases were microscopically reviewed and the diagnosis classified into 10 categories. Results: From the 2395 lesions, 315 (13.1%) occurred in this age group. The lesions were more common in the female gender (59%) during the second deca…

Pathologymedicine.medical_specialtySoft Tissue Neoplasmbusiness.industryConcordanceResearchOdontologíamedicine.disease:CIENCIAS MÉDICAS [UNESCO]DermatologyCiencias de la saludLesionClinical diagnosisClinical and Experimental DentistryOral and maxillofacial pathologyUNESCO::CIENCIAS MÉDICASmedicineClinicopathological featuresIn patientMucocelemedicine.symptombusinessGeneral Dentistry
researchProduct

Intravascular Papillary Endothelial Hyperplasia: Sonographic and Magnetic Resonance Imaging Appearance With Histopathologic Correlation

2016

Pathologymedicine.medical_specialtymedicine.diagnostic_testbusiness.industrySoft Tissue NeoplasmsMagnetic resonance imagingGeneral MedicineMiddle Agedmedicine.diseaseMagnetic Resonance Imaging030218 nuclear medicine & medical imaging03 medical and health sciences0302 clinical medicineText miningThumbIntravascular papillary endothelial hyperplasia030220 oncology & carcinogenesisHumansMedicineFemaleHemangiomabusinessUltrasonographyReumatología Clínica (English Edition)
researchProduct

Soft tissue sarcoma in Italy: From epidemiological data to clinical networking to improve patient care and outcomes

2019

Sarcomas are rare malignant neoplasms that develop from mesenchymal cells and include a heterogeneous and large group of histological subtypes that may occur at any anatomical site. Soft tissue sarcomas (STS), the focus of this review, account for ≈70‒80% of sarcomas and represent <1% of all cancers. The heterogeneity of STS applies to both their topography and morphology, and 5-year survival can vary widely depending on disease stage and the complex interplay between anatomical site and histology for different STS subtypes. The rarity and heterogeneity of STS, together with other factors, such as the lack of clinical expertise often lead to difficulties and delays in making an accurate …

Registriemedicine.medical_specialtyCancer ResearchHistologyEpidemiologyCancer registrieSoft Tissue NeoplasmsDiseaseEuropean reference networkPatient careClinical expertise03 medical and health sciences0302 clinical medicineEpidemiologymedicinePrevalenceHumansCancer registriesRegistries030212 general & internal medicineStage (cooking)Intensive care medicineSoft tissue sarcomaReference centresbusiness.industrySoft tissue sarcomaCancer registries; Epidemiology; European reference network; Histology; Incidence; Italian rare cancer network; Prevalence; Reference centres; Regional variability; Soft tissue sarcoma; Epidemiology; Oncology; Cancer ResearchIncidenceReference centreCancerSarcomaRegional variabilitymedicine.diseaseItalyOncology030220 oncology & carcinogenesisItalian rare cancer networkPatient CarebusinessLarge groupHuman
researchProduct

Analysis of p53 and mdm2 proteins in malignant fibrous histiocytoma in absence of gene alteration: prognostic significance.

2000

TP53 and MDM2 genes and their protein expression were evaluated in frozen and paraffin-embedded tissue from 27 patients with malignant fibrous histiocytoma to elucidate the relationship between them, their implication in tumor progression mechanisms and their possible diagnostic-prognostic value in malignant fibrous histiocytoma. Single-strand conformation polymorphism analysis and direct sequencing of polymerase chain reaction-amplified DNA were used to establish two TP53 mutations (7.4%): a point mutation and a 63-bp duplication. Amplification of the MDM2 gene was observed in two tumors (7.4%) by means of Southern-blot analysis, one of them also carrying the TP53 point mutation. Immunohis…

Tumor suppressor geneBlotting WesternSoft Tissue NeoplasmsBiologyPolymerase Chain ReactionPathology and Forensic MedicineImmunoenzyme TechniquesMiceProto-Oncogene ProteinsGene duplicationGene expressionAnimalsHumansneoplasmsMolecular BiologyGeneTP53 Gene MutationPolymorphism Single-Stranded ConformationalCell NucleusMice Inbred BALB CHistiocytoma Benign FibrousPoint mutationNuclear ProteinsSingle-strand conformation polymorphismProto-Oncogene Proteins c-mdm2Cell BiologyGeneral MedicineDNA NeoplasmMolecular biologyNeoplasm ProteinsSurvival RateBlotting SouthernTumor progressionMutationCancer researchNeoplasm Recurrence LocalTumor Suppressor Protein p53Virchows Archiv : an international journal of pathology
researchProduct